Clinical Trials Browser

Completed × Advanced/Metastatic Solid Tumors × 90 days × Clear all

NCT04501276 2026-01-08

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors